Foot @entity1066 in @entity1 with @entity6 present an increasing burden to healthcare. @entity6029 ( @entity6029 ) is a well established treatment option for many of these @entity1066 , but little seems to be known about the final outcome once healing has been reached. The study examined healing and final outcome after @entity6029 treatment among @entity1 with @entity6 . During a 22-month period, 15 consecutive @entity1 with a total of 17 @entity1066 started treatment with a @entity6029 . Three @entity1 (three @entity1066 ) were lost to @entity12652 ( @entity12652 ). Average @entity12652 was 91 weeks. The @entity1 were followed with emphasis on healing, complications during @entity12652 , footwear, compliance, and frequency of visits. All @entity1066 healed, some after additional surgery. During @entity12652 , control visits were performed at an average of one visit every 4.7 weeks. Notwithstanding this, a high frequency of @entity1066 and/or other complications was noticed. Only four @entity1 out of 12 remained without any new ( @entity1066 ) problem during @entity12652 . @entity6029 proved to be a very efficient tool to heal @entity1411 , but the recurrence rate and frequency of other complications remained very high. These data show how difficult it is to achieve reliable (secondary) preventive general foot care, and to prescribe and manufacture reliable footwear.

Outcome and recurrence rate of diabetic foot ulcers treated by a total contact cast: short-term XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes'] @entity12652 :: ('MESH:C537491', 'Disease') :: ['follow-up', 'FU'] @entity1066 :: ('MESH:D014456', 'Disease') :: ['ulcer', 'ulcer recurrence', 'ulcers'] @entity1411 :: ('MESH:D016523', 'Disease') :: ['neuropathic foot ulcers'] @entity6029 :: ('MESH:D013478', 'Disease') :: ['TCC', 'Total contact cast']
@entity12652 :: (MESH:C537491,Disease) :: ['follow-up']
